BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Novocure Reports Third Quarter 2025 Financial Results

  October 31, 2025

   · 

  17 min read
• Press Releases

  Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results

  October 31, 2025

   · 

  15 min read
• Press Releases

  KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting

  October 31, 2025

   · 

  4 min read
• Press Releases

  Foundation Medicine and Manifold Partner to Accelerate Drug Discovery and Development by Bringing AI-Enabled Analytics to FoundationInsights®

  October 31, 2025

   · 

  3 min read
• Press Releases

  Sonoma Biotherapeutics Announces Upcoming Poster Presentation at the 10th Annual Symposium on Hidradenitis Suppurativa Advances (SHSA)

  October 31, 2025

   · 

  1 min read
• Press Releases

  Satellos to Participate in November 2025 Investor Conferences

  October 31, 2025

   · 

  1 min read
• Press Releases

  Flare Therapeutics to Present Correlative Biomarker Analysis from the FX-909 Phase 1A Clinical Study at Upcoming SITC 2025 40th Anniversary Annual Meeting

  October 31, 2025

   · 

  2 min read
• Press Releases

  Avance Clinical Launches Renal and Cardiometabolic Center of Excellence to Optimize Patient Recruitment to Elevate Study Success

  October 31, 2025

   · 

  3 min read
• Press Releases

  Dogwood Therapeutics to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

  October 31, 2025

   · 

  3 min read
• Press Releases

  Nouscom to Present New Positive Phase 1b/2 Clinical and Translational Data on NOUS-209 Immunogenicity and Cancer Interception Potential in Lynch Syndrome Carriers at SITC 2025

  October 31, 2025

   · 

  7 min read